908 Devices (MASS) Long-Term Debt Repayments (2021 - 2023)

908 Devices (MASS) reported Long-Term Debt Repayments of $15.0 million for Q1 2023, little changed quarter-over-quarter from $15.0 million in Q4 2022.

908 Devices (MASS) Long-Term Debt Repayments (2021 - 2023) Analysis & Trends

908 Devices (MASS) has 3 years of Long-Term Debt Repayments data on file, last reported at $15.0 million in Q1 2023.

  • Long-Term Debt Repayments for Q1 2023 came in at $15.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $15.0 million (down 49.15% YoY), and the FY2023 annual result was $15.0 million, down 75.0% from the prior year.
  • Long-Term Debt Repayments steadied at $15.0 million in Q1 2023 per MASS's latest filing, from $15.0 million in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $15.0 million in Q4 2022 and troughed at $500000.0 in Q1 2021.
  • A 3-year average of $11.2 million and a median of $14.8 million in 2021 frame the typical range for Long-Term Debt Repayments.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 1.00 Bn
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn -
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn -
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn -
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn -
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn -
10 908 Devices 298.78 Mn 187.04 Mn 6.88 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 15.00 Mn
Mar 31, 2023 15.00 Mn
Dec 31, 2022 15.00 Mn
Dec 31, 2022 15.00 Mn
Jun 30, 2021 14.50 Mn
Jun 30, 2021 14.50 Mn
Mar 31, 2021 500,000.00
Mar 31, 2021 500,000.00